Literature DB >> 20673608

The effect of hormonal status on the expression of estrogen and progesterone receptor in vaginal wall and periurethral tissue in urogynecological patients.

Christine E Skala1, Ilka B Petry, Stefan B Albrich, Alexander Puhl, Gert Naumann, Heinz Koelbl.   

Abstract

OBJECTIVE: Our objective was to study the expression of estrogen receptor (ER) isoforms ER alpha (α) and ER beta (β) and of progesterone receptor (PR) in the vaginal wall and in periurethral tissue of women who underwent urogynecological surgical treatment with reference to estrogen status. STUDY
DESIGN: The study included 89 patients undergoing vaginal surgery for urogynecological conditions. Patients' history and clinical data including estrogen status and body mass index (BMI) were evaluated. Biopsies from the vaginal wall and from periurethral tissue were obtained during surgery. The expression of ER α and β and of PR in vaginal wall and periurethral tissue was measured by RT-PCR.
RESULTS: Nine patients were premenopausal. Eighty women were menopausal, of whom 21 were taking estrogen/progestin replacement therapy (HRT), 20 used local estrogen, and 39 had no endocrine treatment. Neither BMI nor age had any influence on the expression of ER and PR. Menopausal women showed a higher amount of PR expression in vaginal tissue than premenopausal women. Women with no endocrine treatment showed a lower amount of ER β expression in vaginal tissue.
CONCLUSION: Steroid receptors are expressed in periurethral and vaginal tissue. The receptor expression varies with hormonal changes only in vaginal tissue. Vaginal tissue seems to be more sensitive to estrogen than periurethral tissue.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673608     DOI: 10.1016/j.ejogrb.2010.07.006

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse.

Authors:  Christine Elisabeth Skala; Ilka Brigitte Petry; Stefan Albrich; Alexander Puhl; Gert Naumann; Heinz Koelbl
Journal:  Int Urogynecol J       Date:  2010-11-24       Impact factor: 2.894

Review 2.  Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women.

Authors:  Irwin Goldstein; Brian Dicks; Noel N Kim; Rose Hartzell
Journal:  Sex Med       Date:  2013-12       Impact factor: 2.491

3.  Expression of ezrin in vagina cells of postmenopausal rats after dietary administration of omega-3 Fatty Acid formula.

Authors:  Hae-Hyeog Lee; Tae-Hee Kim; Junsik Park; Arum Lee; Yongsoon Park; Dong Won Byun; Min Jung Kim; Heesook Lim
Journal:  J Menopausal Med       Date:  2014-12-24

Review 4.  The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women.

Authors:  Yashini Govender; Iwona Gabriel; Vatche Minassian; Raina Fichorova
Journal:  Front Cell Infect Microbiol       Date:  2019-05-01       Impact factor: 5.293

5.  Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques.

Authors:  Sukanya Jaroenporn; Nontakorn Urasopon; Gen Watanabe; Suchinda Malaivijitnond
Journal:  J Reprod Dev       Date:  2014-04-21       Impact factor: 2.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.